PAhR Therapeutics is a clinical-stage company focused on developing novel mechanisms for the treatment of pulmonary arterial hypertension (PAH)
Company Details
- Address
- Boston, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.pahrtx.com
- Keywords
- Boston.
- HQ
- Boston, MA
Pahr Therapeutics Questions
Pahr Therapeutics's website is http://www.pahrtx.com
Pahr Therapeutics's LinkedIn profile is https://www.linkedin.com/company/pahr-therapeutics
Pahr Therapeutics's industry is
Biotechnology Research
Pahr Therapeutics's top competitors are
Artbio,
Ikena Oncology,
Heartlab,
An Venture Partners,
Alphamab Oncology,
Maplight Therapeutics, Inc.,
Embody Orthopaedic,
Recornea,
Wanda Health,
Ra Capital Management.
Pahr Therapeutics's categories are Biotechnology Research
